Evidence map›Paper›PMID 39948559›Full record

ArticleBMC surgery2025

Risk assessment of hyperbilirubinemia using a three-factor model after cardiac surgery.

Weibin Lin, Bin Chen, Kevin Yang, Liting Kuang

Abstract read
In one paragraph

Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Weibin Lin *Department of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Bin Chen *Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Kevin YangZhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
Liting KuangDepartment of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. kuanglt@mail.sysu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyperbilirubinemia (HB) is a common occurrence after cardiopulmonary bypass and often results in increased rates of complications.

methodsWe conducted a study on 411 patients who underwent cardiac surgery with extracorporeal circulation and divided them into a training set and a validation set. Least absolute shrinkage and selection operator (LASSO) regression was employed to screen out variables. Multivariate logistic regression was subsequently applied to establish prediction models, which were then evaluated using receiver operating characteristic (ROC) curves and calibration plots. Finally, restricted cubic splines (RCSs) curve pairs were used to calculate the adjusted ORs for each independent risk factor.

resultsA clinical prediction model based on preoperative bilirubin elevation, aortic clamp time and intraoperative red blood cell (RBC) transfusion was successfully developed. The model presented an ROC of 0.855 (0.808, 0.901) in the training set. The validation set demonstrated a promising ROC of 0.839 (0.761, 0.917), and the calibration curve closely approximated the true incidence. The risk of postoperative HB was increased when the aortic clamp time was greater than 133 min, when the red blood transfusion volume was greater than 275 ml or when the preoperative total bilirubin concentration was greater than 16.65 mol/L.

conclusionIn this study, the aortic clamp time was identified as a crucial factor for postoperative HB during cardiac surgery. A three-factor prediction model that includes the aortic clamp time for the prediction of HB after cardiac surgery was successfully established. Furthermore, patients with hyperbilirubinemia post-surgery had a worse short-term prognosis.

Indexed as

Cardiac Surgical ProceduresCardiopulmonary BypassHyperbilirubinemiaPostoperative ComplicationsAgedBilirubinErythrocyte TransfusionFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsROC CurveBilirubinBlood transfusionCardiac surgeryInternal validationTotal bilirubin

Identifiers

PMID39948559
PMCPMC11823160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.